GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Exactech Inc (NAS:EXAC) » Definitions » Debt-to-EBITDA

Exactech (Exactech) Debt-to-EBITDA : 0.36 (As of Sep. 2017)


View and export this data going back to 1996. Start your Free Trial

What is Exactech Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Exactech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2017 was $0.0 Mil. Exactech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2017 was $14.0 Mil. Exactech's annualized EBITDA for the quarter that ended in Sep. 2017 was $38.5 Mil. Exactech's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2017 was 0.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Exactech's Debt-to-EBITDA or its related term are showing as below:

EXAC's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.24
* Ranked among companies with meaningful Debt-to-EBITDA only.

Exactech Debt-to-EBITDA Historical Data

The historical data trend for Exactech's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exactech Debt-to-EBITDA Chart

Exactech Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 0.90 0.53 0.40 0.74

Exactech Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 -0.89 0.33 0.28 0.36

Competitive Comparison of Exactech's Debt-to-EBITDA

For the Medical Devices subindustry, Exactech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exactech's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Exactech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Exactech's Debt-to-EBITDA falls into.



Exactech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Exactech's Debt-to-EBITDA for the fiscal year that ended in Dec. 2016 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 20) / 26.971
=0.74

Exactech's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2017 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 14) / 38.452
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2017) EBITDA data.


Exactech  (NAS:EXAC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Exactech Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Exactech's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Exactech (Exactech) Business Description

Traded in Other Exchanges
N/A
Address
Exactech Inc develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally.
Executives
Krusen W Andrew Jr director C/O FLORIDA BANKS INC, 5210 BELFORD ROAD - SUITE 310, JACKSONVILLE FL 32256
James G Binch director C/O MEMRY CORPORATION, 3 BERKSHIRE BOULEVARD, BETHEL CT 06801

Exactech (Exactech) Headlines

From GuruFocus

Meridian Funds Comments on Exact Sciences Corp

By Holly LaFon Holly LaFon 03-08-2016

Exactech Inc. (EXAC) CFO and Treasurer Joel C Phillips sells 2,497 Shares

By GuruFocus Research GuruFocus Editor 05-04-2010

Exactech Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 05-05-2010

Exactech Inc. (EXAC) CEO and Chairman, 10% Owner R William Petty sells 20,000 Shares

By GuruFocus Research GuruFocus Editor 12-12-2009

Mario Gabelli Ups His Holdings in EXAC, TWIN and LAYN

By Monica Wolfe Monica Wolfe 06-28-2013

Exactech Inc. Reports Operating Results (10-K)

By gurufocus 10qk 03-16-2011

Exactech Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-09-2010

Exactech Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2009